乳房植入物市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球乳房植入物市场规模达26亿美元，预计2034年将以7.9%的复合年增长率成长，达到57亿美元。这得归功于隆乳手术数量的成长、植入物设计技术的创新以及人们对外观的日益关注。隆乳手术因其较高的满意度、个人化的效果以及相对安全的微创性，已成为一种广受欢迎的美容手术，尤其是在已开发地区。手术技术的进步，包括更快的恢復时间和更低的併发症风险，也提升了隆乳手术的吸引力。

此外，社会对塑身手术（尤其是以美观和自信为重点的手术）的接受度日益提高，也推动了隆乳手术的日益普及。越来越多的女性选择隆乳，这不仅是出于美观考虑，也是为了解决乳房不对称等功能性问题，以及乳房切除术或其他疾病后进行乳房重建的需求。隆乳手术能够根据每个人的体型和美学目标提供个人化解决方案，这极大地推动了需求的成长。此外，包括微创手术在内的外科技术的进步，使这些手术更加安全有效，恢復时间更短，且併发症风险更低。

2024年，硅胶假体市场规模达24亿美元。硅胶假体在隆乳和乳房重建手术（尤其是在乳房切除术后）中的应用日益受到青睐，这主要归功于其自然的外观和触感以及良好的耐用性。硅胶假体深受整形外科医师的青睐，因为它们不易起皱或起波纹，并且能够带来更平滑、更自然的美感。这些假体已获得美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 的批准，可用于隆乳和乳房重建手术。假体尺寸和形状的日益多样化也促进了它们的普及，使其适用于更广泛的患者群体。此外，硅胶假体在修復手术中的应用也日益增多，进一步支撑了市场的成长。

2024年，圆形乳房植入物市场占据了相当大的份额，预计到2034年将成长至43亿美元。圆形植入物尤其受欢迎，因为它们能够提供更挺拔、更圆润的外观，并且植入位置灵活。它们可以透过任何类型的切口植入，包括腋下切口，从而减少可见疤痕，使其成为许多患者的首选。此外，圆形植入物在成本效益、手术便利性和更广泛的尺寸选择方面具有灵活性，这促使其使用率不断上升。预计该市场的成长将受到多种选择的推动，包括盐水和硅胶材质的植入物，以及植入物技术的持续改进。

2024年，美国乳房植入物市场规模达8.64亿美元，隆乳手术数量的成长以及医疗设施的进步推动了市场的成长。主要参与者的加入以及新型先进植入物的开发，为市场扩张提供了支撑。美容手术的接受度不断提高，加上乳房植入物价格的日益亲民，使得更广泛的人群能够接受，从而提高了其采用率。

全球乳房植入物产业的主要参与者包括 AbbVie、Euromi、广州万和塑胶材料、Sientra、POLYTECH Health & Aesthetics 和 Mentor Worldwide LLC 等。这些公司专注于产品创新，并透过策略伙伴关係和合作扩大市场覆盖范围。他们也加大了对研发的投入，以提高植入物品质、提升病患满意度并降低手术风险。此外，许多公司正在积极开发更广泛的植入物尺寸、形状和材料，以满足不同患者的需求，这有助于增强其在市场上的竞争地位。此外，采用更先进的製造流程使这些公司能够提供更多客製化、更高品质的植入物，从而进一步提升其市场份额。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 隆乳手术数量不断增加
    • 乳癌发生率不断上升
    • 技术进步
    • 整形外科医生数量不断增加
  • 产业陷阱与挑战
    • 植入手术费用高昂
    • 併发症风险
• 成长潜力分析
• 监管格局
  • 我们
  • 欧洲
• 技术格局
• 川普政府关税
  • 对贸易的影响
    • 贸易量中断
    • 报復措施
  • 对产业的影响
    • 供应方影响（原料）
      • 主要材料价格波动
      • 供应链重组
      • 生产成本影响
    • 需求面影响（售价）
      • 价格传导至终端市场
      • 市占率动态
      • 消费者反应模式
  • 受影响的主要公司
  • 策略产业反应
    • 供应链重组
    • 定价和产品策略
    • 政策参与
  • 展望与未来考虑
• 报销场景
• 定价分析
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 差距分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 盐水植入物
• 硅胶植入物

第六章：市场估计与预测：依形状，2021 - 2034 年

• 主要趋势
• 圆形的
• 解剖学

第七章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 隆乳
• 乳房重建

第八章：市场估计与预测：按植入物纹理，2021 - 2034 年

• 主要趋势
• 光滑的
• 纹理

第九章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 诊所
• 其他最终用户

第十章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 瑞典
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 泰国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥伦比亚
  • 智利
  • 秘鲁
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 以色列
  • 土耳其

第 11 章：公司简介

• AbbVie
• Establishment Labs
• Euromi
• GC Aesthetics
• Groupe Sebbin
• Guangzhou Wanhe Plastic Material
• Hansbiomed
• IDEAL Implant
• Laboratoires Arion
• Mentor Worldwide LLC (Johnson & Johnson)
• POLYTECH Health & Aesthetics
• Prayasta 3D Inventions
• Shanghai Kangning Medical Device
• Sientra

The Global Breast Implants Market was valued at USD 2.6 billion in 2024 and is estimated to grow at a CAGR of 7.9% to reach USD 5.7 billion by 2034, driven by the rise in breast augmentation surgeries, technological innovations in implant designs, and an increasing focus on physical appearance. Breast augmentation has become a widely sought-after cosmetic procedure, particularly in developed regions, due to its high satisfaction rate, personalized results, and relatively safe, minimally invasive procedures. Advances in surgical techniques, including quicker recovery times and reduced complication risks, have also contributed to the procedure's appeal.

Additionally, the increasing societal acceptance of body-enhancing procedures, particularly those focused on aesthetics and self-confidence, has contributed to the growing popularity of breast implants. Women are increasingly opting for breast augmentation not just for cosmetic reasons but also to address functional issues like asymmetry and the need for breast reconstruction following mastectomies or other medical conditions. The ability of breast implants to offer customized solutions tailored to everyone's body shape and aesthetic goals has significantly driven demand. Moreover, advances in surgical techniques, including minimally invasive methods, have made these procedures safer and more effective, with faster recovery times and reduced risk of complications.

The silicone implant segment generated USD 2.4 billion in 2024. The increasing preference for silicone implants for breast augmentation and reconstruction, especially after mastectomy, is largely due to their natural look and feel, as well as their durability. Silicone implants are highly favored by plastic surgeons because they are less prone to wrinkles or rippling and provide a smoother, more natural aesthetic. These implants are approved by both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for both augmentation and reconstruction procedures. The growing variety of implant sizes and profiles has also contributed to their popularity, making them suitable for a broad range of patients. Moreover, silicone implants are increasingly used for revision surgeries, further supporting market growth.

The round breast implants segment accounted for a substantial share in 2024 and is expected to grow to USD 4.3 billion by 2034. Round implants are particularly popular due to their ability to provide a more lifted, rounder appearance and flexibility in placement. They can be inserted through any type of incision, including underarm incisions, which reduces visible scarring, making them a preferred choice for many patients. Furthermore, round implants offer flexibility based on cost-effectiveness, surgical ease, and a wider range of size options, contributing to their increasing usage. The growth of this segment is expected to be bolstered by the availability of diverse options, including both saline and silicone versions, and the continued development of improved implant technologies.

United States Breast Implants Market generated USD 864 million in 2024, with an increase in breast augmentation procedures and advancements in healthcare facilities driving market growth. The presence of major players and the development of new, advanced implant products support this market expansion. The growing acceptance of aesthetic surgery, as well as the increasing affordability of breast implants, has made them more accessible to a broader demographic, resulting in higher adoption rates.

Key players in the Global Breast Implants Industry include AbbVie, Euromi, Guangzhou Wanhe Plastic Material, Sientra, POLYTECH Health & Aesthetics, and Mentor Worldwide LLC, among others. These companies focus on product innovation and expanding their market reach through strategic partnerships and collaborations. They are also increasingly investing in research and development to improve implant quality, enhance patient satisfaction, and reduce surgical risks. Furthermore, many of these companies are actively working to develop a wider range of implant sizes, shapes, and materials to cater to diverse patient needs, which helps strengthen their competitive position in the market. Additionally, adopting more advanced manufacturing processes has enabled these companies to offer more customized, higher-quality implants, further boosting their market share.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.1.1 Research approach
  • 1.1.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.1.3 Base year calculation
  • 1.1.4 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.1.5 Primary sources
  • 1.1.6 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of breast augmentation procedures
    • 3.2.1.2 Growing breast cancer incidence
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Increasing number of plastic surgeons
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of implantation procedure
    • 3.2.2.2 Risk of complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technological landscape
• 3.6 Trump administration tariffs
  • 3.6.1 Impact on trade
    • 3.6.1.1 Trade volume disruptions
    • 3.6.1.2 Retaliatory measures
  • 3.6.2 Impact on the Industry
    • 3.6.2.1 Supply-side impact (raw materials)
      • 3.6.2.1.1 Price volatility in key materials
      • 3.6.2.1.2 Supply chain restructuring
      • 3.6.2.1.3 Production cost implications
    • 3.6.2.2 Demand-side impact (selling price)
      • 3.6.2.2.1 Price transmission to end markets
      • 3.6.2.2.2 Market share dynamics
      • 3.6.2.2.3 Consumer response patterns
  • 3.6.3 Key companies impacted
  • 3.6.4 Strategic industry responses
    • 3.6.4.1 Supply chain reconfiguration
    • 3.6.4.2 Pricing and product strategies
    • 3.6.4.3 Policy engagement
  • 3.6.5 Outlook and future considerations
• 3.7 Reimbursement scenario
• 3.8 Pricing analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis
• 3.11 Future market trends
• 3.12 GAP analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Saline implant
• 5.3 Silicone implant

Chapter 6 Market Estimates and Forecast, By Shape, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Round
• 6.3 Anatomical

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Breast augmentation
• 7.3 Breast reconstruction

Chapter 8 Market Estimates and Forecast, By Implant Texture, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Smooth
• 8.3 Textured

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Clinics
• 9.4 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Sweden
  • 10.3.7 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Thailand
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
  • 10.5.4 Columbia
  • 10.5.5 Chile
  • 10.5.6 Peru
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Israel
  • 10.6.5 Turkey

Chapter 11 Company Profiles

• 11.1 AbbVie
• 11.2 Establishment Labs
• 11.3 Euromi
• 11.4 GC Aesthetics
• 11.5 Groupe Sebbin
• 11.6 Guangzhou Wanhe Plastic Material
• 11.7 Hansbiomed
• 11.8 IDEAL Implant
• 11.9 Laboratoires Arion
• 11.10 Mentor Worldwide LLC (Johnson & Johnson)
• 11.11 POLYTECH Health & Aesthetics
• 11.12 Prayasta 3D Inventions
• 11.13 Shanghai Kangning Medical Device
• 11.14 Sientra